unanimously elected Kyle Brown as Chief Executive Officer ("CEO") of the Company, effective January 1, 2024, to succeed the Company's current CEO, Steven L. Brown.
Departed
Albert M. Campbell, III
Executive Vice President and Chief Financial Officer
Mid-America Apartments, L.P.
Effective
2024-03-31
Successor
A. Clay Holder
Filed
September 6, 2023, 7:59 PM ET
On September 6, 2023, Mid-America Apartment Communities, Inc. (the “Company”) announced that Albert M. Campbell, III will be retiring from his position as Executive Vice President and Chief Financial Officer of the Company, effective March 31, 2024 (the “Transition Date”).
Appointed
A. Clay Holder
Chief Financial Officer
Mid-America Apartments, L.P.
Effective
2024-03-31
Filed
September 6, 2023, 7:59 PM ET
A. Clay Holder, the Company’s current Senior Vice President and Chief Accounting Officer, will assume responsibilities as the Company’s Chief Financial Officer effective upon Mr. Campbell’s retirement.
Appointed
Martin Huber
President and Chief Executive Officer
Mersana Therapeutics, Inc.
Effective
2023-09-11
Filed
September 6, 2023, 7:59 PM ET
Martin Huber, M.D., was appointed as the Company’s President and Chief Executive Officer, effective as of September 11, 2023
Departed
Anna Protopapas
President and Chief Executive Officer
Mersana Therapeutics, Inc.
Effective
2023-09-10
Successor
Martin Huber, M.D.
Filed
September 6, 2023, 7:59 PM ET
Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics, Inc. (the “Company”), provided the Company with notice of her desire and intention to retire, and on September 6, 2023, the Company announced Ms. Protopapas’ retirement effective as of September 10, 2023
On August 30, 2023, Farmer Bros. Co., a Delaware corporation (the “Company”), and Deverl Maserang, the Company’s President and Chief Executive Officer, agreed that Mr. Maserang’s employment with the Company will be terminated, without cause, effective September 30, 2023.
Elizabeth T. Beale notified the Company of her decision to resign as Chief Financial Officer & Senior Vice President/Finance and principal financial and accounting officer of the Company and as Chief Financial Officer & Executive Vice President of the Bank.
On September 6, 2023, ALX Oncology Holdings Inc. (the “Company”) appointed Jason Lettmann, age 46 and a current member of the Company’s Board of Directors (the “Board”), as the Company’s Chief Executive Officer.
As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
the Board of Directors of Trupanion, Inc. (the “Company”) appointed Fawwad Qureshi, as the Company’s Chief Financial Officer, with services to begin September 25, 2023.
On September 5, 2023, The Honest Company, Inc. (the “Company” ) announced the appointment of David Loretta as the Company’s Chief Financial Officer, effective September 25, 2023
Appointed
Stefan Chkautovich
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
On August 31, 2023, Southern Missouri Bancorp, Inc. (the “Company”), the holding company for Southern Bank (the “Bank”), hired Stefan Chkautovich to serve as the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective September 18, 2023.
On September 6, 2023, the Company announced the appointment of Kevin Watson as the Company’s Executive Vice President, Chief Financial Officer (“CFO”) effective as of September 7, 2023.
Appointed
Darrell Campbell
Executive Vice President and Chief Financial Officer
On September 6, 2023, Schneider National, Inc. (the "Company") announced that Darrell Campbell has been appointed to serve as the Company's Executive Vice President and Chief Financial Officer (“CFO”), effective September 30, 2023.
Departed
Stephen L. Bruffett
Executive Vice President and Chief Financial Officer
The Company previously announced on May 23, 2023, that Stephen L. Bruffett, the Company's current Executive Vice President and Chief Financial Officer, would be retiring after a transition period.
On September 5, 2023, Efrain Rivera, Senior Vice President and Chief Financial Officer of Paychex, Inc. (the “Company”), notified the Company of his intention to retire as Chief Financial Officer effective as of end of business on October 12, 2023
Also on September 5, 2023, the Board appointed Robert L. Schrader, age 51, to serve as the Company’s Senior Vice President and Chief Financial Officer effective as of October 13, 2023.
Appointed
James Coogan
Executive Vice President and Chief Financial Officer
On September 5, 2023, the Company announced that its Board of Directors appointed James Coogan, age 42, as the Company’s Executive Vice President and Chief Financial Officer, effective upon the commencement of Mr. Coogan’s full-time employment with the Company expected in October 2023 (the “Effective Date”).
Richard G. Johnson, the former Chief Financial Officer of the Company, who has been serving as a Finance Advisor to the Company since November 16, 2020, will assume the role of interim Chief Financial Officer until a successor to Mr. Finio is identified.
Upon Mr. Campbell’s promotion to CEO, the Company’s current CEO, Jeffrey A. Williams, will serve as CEO Emeritus and an advisor to senior management effective October 1, 2023, for the remainder of fiscal year 2024.
On September 5, 2023, Invivyd, Inc. (the “Company”) announced the appointment of William Duke, age 51, as the Company’s Chief Financial Officer, effective as of September 1, 2023
Xylem's Board appointed Mattew F. Pine, age 52, as the Company's President and Chief Executive Officer to succeed Mr. Decker and to serve as a member of the Board, effective January 1, 2024.
Patrick K. Decker will retire from his position as President and Chief Executive Officer and resign from the Board of Directors ("Board") effective December 31, 2023
the Board appointed Aman Narang, the Company’s current Co-President, Co-Founder and Chief Operating Officer, to succeed Mr. Comparato as Chief Executive Officer of the Company, effective January 1, 2024.
Christopher P. Comparato, Chief Executive Officer and Chairperson of the Board of Toast, Inc. (the “Company”), informed the Company’s Board of Directors (the “Board”) that he will step down as Chief Executive Officer of the Company, effective January 1, 2024.
Departed
Xianchang Ma
Director, Chief Executive Officer and Chief Financial Officer
Tengjun Biotechnology Corp.
Effective
2023-08-03
Successor
Caihong Qu
Filed
September 5, 2023, 7:59 PM ET
who passed away on August 3, 2023
Appointed
(interim)
Caihong Qu
interim Chief Executive Officer and Chief Financial Officer
Tengjun Biotechnology Corp.
Effective
2023-08-10
Filed
September 5, 2023, 7:59 PM ET
On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company
Role change
Doug Rice
Chief Financial Officer and Chief Accounting Officer
After discussions with MiMedx Group, Inc. (the “Company”), including Doug Rice, the Company’s recently appointed Chief Financial Officer, William Phelan, who had previously been serving as Chief Accounting Officer, and the Company agreed that it was in the Company’s best interests to combine the roles of Chief Financial Officer and Chief Accounting Officer into a single position, which Mr. Rice assumed, effective on September 1, 2023.
On September 1, 2023, John McVicar (“Mr. McVicar”) was appointed as Chief Financial Officer of Camber Energy, Inc., a Nevada corporation (the “Company”), replacing Frank W. Barker, Jr. (“Mr. Barker”) as the Company’s Chief Financial Officer.
On August 29, 2023, in connection with the termination of the Master Services Agreement, Sandra A. Gardiner notified the Company of her resignation as the Company’s Acting Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective as of the Termination Date.
Effective November 27, 2023 (the “Effective Date”), Gayle Jardine will step down from her position as Interim Chief Financial Officer of Coda Octopus Group, Inc. (the “Company”), in connection with the appointment of a new Chief Financial Officer as disclosed below.
On September 5, 2023, the Company announced the appointment of Kendra Adams as its Chief Financial Officer, Treasurer and principal financial officer, effective as of Monday September 18, 2023.
On August 30, 2023, Lauren White informed us of her intent to resign from C4 Therapeutics, Inc. (the “ Company ”), effective as of Friday September 15, 2023.
Effective as of September 1, 2023, the Board of Directors (the “ Board ”) of 374Water Inc. (the “ Company ”) appointed Jeff Quick as Interim Chief Executive Officer (“ CEO ”) of the Company.
Departed
John Price
Chief Financial Officer
Assure Holdings Corp.
Effective
2023-11-17
Filed
September 5, 2023, 7:59 PM ET
On August 29, 2023, John Price resigned as Chief Financial Officer of the Company, with such resignation to be effective on November 17, 2023.
Appointed
H. Joseph Prodan
Chief Financial Officer
Bird Global, Inc.
Effective
2023-08-30
Filed
September 5, 2023, 7:59 PM ET
On September 5, 2023, the Board announced its appointment of H. Joseph Prodan to succeed Michael Washinushi as the Company’s Chief Financial Officer, effective on August 30, 2023.
Role change
(interim)
Michael Washinushi
Interim Chief Executive Officer
Bird Global, Inc.
Effective
2023-08-30
Successor
H. Joseph Prodan
Filed
September 5, 2023, 7:59 PM ET
On September 5, 2023, the Board announced its appointment of H. Joseph Prodan to succeed Michael Washinushi as the Company’s Chief Financial Officer, effective on August 30, 2023.
Departed
Scott Sutton
President, Chief Executive Officer and Chairman of the Board
On September 1, 2023, Olin Corporation (the “Company”) announced that, by mutual agreement, Mr. Scott Sutton will step down as the Company’s President, Chief Executive Officer and Chairman of the Board in the first half of 2024.
Jorgen Pedersen ceased to be Chief Operating Officer of the Company and its subsidiaries (the “Company Group”) on July 12, 2023 (the “Separation Date”).
Philip O. Strawbridge stepped down from his position as Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer of Centrus Energy Corp. (the “Company”), effective August 31, 2023.
Appointed
Kevin J. Harrill
Senior Vice President, Chief Financial Officer and Treasurer
the Board of Directors (the “Board”) of the Company appointed Kevin J. Harrill to succeed Philip O. Strawbridge as Senior Vice President, Chief Financial Officer and Treasurer, effective September 1, 2023.
On August 28, 2023, the Company and Mr. D’Amico mutually agreed to terminate Mr. D’Amico’s employment with the Company.
Appointed
Seth Tasker
Chief Executive Officer
INFINITY PHARMACEUTICALS, INC.
Effective
2023-09-01
Filed
September 1, 2023, 7:59 PM ET
On August 29, 2023, the Board approved the appointment, effective as of September 1, 2023, of Seth Tasker, J.D., 45, as Chief Executive Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.